药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pipecuronium
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Eliglustat.
Pipecuronium
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Eliglustat.
Pipecuronium
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Eliglustat.
Pipecuronium
Encorafenib
The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Encorafenib.
Pipecuronium
Ivosidenib
The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Eliglustat.
Pipecuronium
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Eliglustat.
Pipecuronium
Penfluridol
The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Eliglustat.
Pipecuronium
Otilonium
The risk or severity of QTc prolongation can be increased when Otilonium is combined with Eliglustat.
Pipecuronium
Eperisone
The risk or severity of QTc prolongation can be increased when Eperisone is combined with Eliglustat.
Pipecuronium
Fendiline
The risk or severity of QTc prolongation can be increased when Fendiline is combined with Eliglustat.
Pipecuronium
Bedaquiline
The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Eliglustat.
Pipecuronium
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Eliglustat.
Pipecuronium
Prenylamine
The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Eliglustat.
Pipecuronium
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Dexchlorpheniramine maleate.
Pipecuronium
Gilteritinib
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Eliglustat.
Pipecuronium
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Eliglustat.
Pipecuronium
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Eliglustat.
Pipecuronium
Lorcainide
The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Eliglustat.
Pipecuronium
Bunaftine
The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Eliglustat.
Pipecuronium
Nizofenone
The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Eliglustat.